Intravitreal anti-VEGF therapy can ensure a significant visual function improvement in about one third of patients affected by RAP, who underwent to a common clinical practice treatment. Ranibizumab treatement required less number of injections over 12 months.
Treatment of Retinal Angiomatous Proliferation with Intravitreal Anti-VEGF Drugs in Real Life Practice
DANZI, Paola;SEMERARO, Francesco;
2014-01-01
Abstract
Intravitreal anti-VEGF therapy can ensure a significant visual function improvement in about one third of patients affected by RAP, who underwent to a common clinical practice treatment. Ranibizumab treatement required less number of injections over 12 months.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Esaso SuppOphthalmologica esaso 2014.pdf
gestori archivio
Descrizione: Esaso 2014 - Progetto Luce
Tipologia:
Abstract
Licenza:
DRM non definito
Dimensione
719.79 kB
Formato
Adobe PDF
|
719.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
